Longevity Novo Nordisk’s Alzheimer’s GLP-1 gamble failsBy adminNovember 26, 20250 Long shot Phase 3 trial finds semaglutide did not deliver a statistically significant reduction in Alzheimer’s progression. Pharma giant Novo…
Microbiome Novo Nordisk’s GLP-1 Drug Fails to Improve Alzheimer’s SymptomsBy adminNovember 25, 20250 Credit: Juan Gaertner/Science Photo Library/Getty Images The results from two Phase III trials announced this week show Novo Nordisk’s GLP-1…
DNA & Genetics ChatGPT Fails to Flag Retracted and Problematic ArticlesBy adminSeptember 12, 20250 ChatGPT overlooked retractions and other concerns in research articles when prompted to evaluate their quality, highlighting the limitations of the…
